Chewy's AI Bet Is Paying Off - Upgrade and a Clear Swing Trade

Hook and thesis

Chewy just gave investors something concrete to hang their hat on: management is pointing to AI-driven efficiencies that materially expand margins. The March 25, 2026 earnings reaction was loud for a reason - company commentary and guidance moved the profit story from aspirational to measurable. If Chewy can convert tens of millions a year of AI savings into higher EBITDA, the multiple on today’s enterprise value compresses quickly versus where the stock trades now.

My thesis is simple and actionable: the market underestimates how quickly Chewy's AI and automation investments will flow through to operating profit. That makes CHWY a tactical long with a defined entry at $26.60, a stop at $23.50, and a primary target of $36.00 over a mid-term horizon of 45 trading days. The upgrade is premised on management's guidance and the math that follows - if Chewy hits guidance for fiscal 2026, the company looks materially cheaper on an EV/EBITDA basis than the headline multiples imply today.

What Chewy does and why investors should care

Chewy is the largest online pet retailer in the U.S., selling pet food, pharmacy products, telehealth services, and subscription-based Autoship deliveries. The recurring nature of Autoship and expanding higher-margin services like pharmacy and telehealth are the fundamental levers for margin expansion. Importantly, management is now explicitly quantifying the impact of AI on SG&A and fulfillment costs - that converts a narrative into a financial lever that can be modeled.

The fundamental driver - AI turning revenue growth into real profits

On 03/25/2026 Chewy reported results showing steady customer adds and unit economics that are improving. Highlights that support the profit thesis:

• Reported 8.1% sales growth to $3.26 billion for the reported period (Q4), with management guiding fiscal 2026 net sales growth of roughly 9% to $13.7 billion.
• Management expects EBITDA margins to expand to 6.7% in fiscal 2026, and attributes a meaningful portion of that improvement to AI-powered cost efficiencies projected to save tens of millions annually.
• Free cash flow is already positive and meaningful - trailing free cash flow stood at $486,994,000, showing that profitable growth is achievable as margins move higher.

Those three items together are the core of my upgrade. Revenue growth is modest but steady; AI is a lever to compress operating expenses; and FCF shows the business converts earnings into cash.

Support from valuation math

Here is the simple arithmetic investors should focus on. Chewy's market snapshot shows a market capitalization of about $11.02B and an enterprise value near $9.06B. If management reaches the 6.7% EBITDA margin target on $13.7B of revenue, implied EBITDA is roughly $918M (13,700 x 0.067 = 917.9).

At that EBITDA run-rate, the current enterprise value implies an EV/EBITDA of about 9.9x (9.06B / 917.9M). That is a meaningful re-rating from the current EV/EBITDA of 27.8x baked into trailing numbers and the market's recent pricing - and it assumes Chewy does not need heroic revenue growth to justify the valuation improvement. In short, the path to a sub-10x EV/EBITDA multiple is credible if Chewy executes on margin guidance and the promised AI cost savings arrive.

Key supporting numbers

• Market cap: $11.02B
• Enterprise value: $9.06B
• Trailing free cash flow: $486.99M
• Guidance: Fiscal 2026 net sales ~ $13.7B; EBITDA margin target 6.7%
• Company operating metrics: solid Autoship penetration and customer additions noted in results (813,000 new customers in the reported period)

Technical and market setup

From a technical perspective, CHWY is not in overstretched territory. The stock sits above its 10-day SMA ($24.60) and 20-day SMA ($25.44) and is below the 50-day SMA ($27.34), giving buyers a reasonable risk entry with nearby support. Momentum indicators show modest strength - RSI around 54.6 and a bullish MACD histogram. Short interest remains meaningful but tradable - recent short interest settled near 16.2M shares with a days-to-cover under 2, which can accentuate moves to the upside on positive fundamental news.

Trade plan (actionable)

• Direction: Long CHWY.
• Entry: $26.60 (aggressive entry taken near current price). The stock is trading near $26.57; enter at $26.60 to ensure execution.
• Stop loss: $23.50. Place the stop below recent short-term support and the 52-week low area ($22.74) buffer to allow for noise while limiting downside.
• Target: $36.00. This target reflects partial realization of the margin story and re-rating to a mid-teens multiple on an improving EBITDA trajectory.
• Horizon: Mid term (45 trading days). I expect the market to reprice the business within 11-45 trading days as quarterly commentary is digested and AI savings start to be quantified in follow-up reports and investor calls.

Rationale for horizon: AI savings and margin commentary have already moved sentiment; the next 45 trading days should cover further investor updates, incremental quarterly data, and follow-through in analyst models. If Chewy's execution stalls, the stop protects capital quickly.

Catalysts

• Quarterly follow-up commentary and early release of quantifiable AI cost savings - management has already telegraphed 'tens of millions' in annual savings; concrete quarterly cadence will be a re-rating catalyst.
• Higher-margin growth from pharmacy and telehealth services scaling faster than expected.
• Positive sell-side model revisions driven by the 6.7% EBITDA margin guide - revisions can accelerate flows into the stock.
• Technical squeeze if short interest remains elevated and results/guide trigger short covering.

Risks and counterarguments

Below are the main risks that could derail the trade, followed by a direct counterargument to the bullish case.

• Execution risk on AI initiatives: AI projects often take longer to implement than planned and can deliver lower-than-expected savings in the first year.
• Competition and margin pressure: Competitors such as large omnichannel retailers or specialized pet chains could push prices or invest in their own logistics, compressing gross margins.
• Valuation complacency: The current P/E sits elevated (near 50x trailing numbers); if the market focuses on near-term EPS dilution from investments or slower sales, multiple compression could occur before margins fully expand.
• Macro and discretionary spending risk: Pet products are resilient but not immune to broader retail weakness - an unexpected slowdown in consumer spending could reduce frequency or average order size.
• Execution on higher-margin services: Pharmacy, telehealth, and insurance products are promising but require regulatory compliance and marketing spend to scale; missteps would delay margin improvement.

Counterargument

The strongest counter to this trade is valuation impatience: if investors demand immediate EPS improvement, the stock could trade down even if the longer-term AI benefits are real. The headline P/E near 50x (trailing) means Chewy needs to show concrete margin improvements quickly, not just projections. If AI savings are delayed or only partially realized in fiscal 2026, the re-rating won't happen and the stock could revert to prior multiples.

What would change my mind

I would downgrade this trade if one or more of the following occurs:

• Management withdraws or materially lowers fiscal 2026 guidance for either sales or EBITDA margin.
• Quarterly updates show AI savings materially below the "tens of millions" guidance or reveal unexpected implementation costs that offset savings.
• Significant deterioration in Autoship retention or net sales per customer that suggests revenue quality is weakening.

Conclusion

Chewy's late-March commentary moved the needle for me. The company is no longer merely promising future efficiency - it is guiding to a specific EBITDA margin uplift that is largely driven by AI. If management executes, the valuation arithmetic is straightforward: $13.7B of sales at 6.7% EBITDA produces nearly $918M of EBITDA, which makes today's enterprise value look inexpensive on a forward EV/EBITDA basis. That supports an upgrade and a tactical long with a clear entry at $26.60, a stop at $23.50, and a target of $36.00 over the next 45 trading days.

For traders, this is a structured way to express bullishness on AI-driven margin improvement without overpaying for optionality. For longer-term investors, the same thesis holds - Chewy's recurring revenue base and expanding services provide a durable runway for profits if AI initiatives scale as management expects.

Trade voice note: This is a disciplined swing trade that leans on a concrete margin guide and a measurable AI savings claim. Keep position size appropriate and follow the stop - the risk/reward is attractive if execution remains on plan.